Cancer Council Australia Keratinocyte Cancers Guideline Working Party. Follow-up after treatment for keratinocyte cancer. In: Clinical practice guidelines for keratinocyte cancer. Sydney: Cancer Council Australia; 2019. Accessed Feb 2021. https://wiki.cancer.org.au/australia/Guidelines:Keratinocyte_carcinoma
Chen AC, Martin AJ, Choy B, Fernández-Peñas P, Dalziell RA, McKenzie CA, et al. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. N Engl J Med 2015;373(17):1618-26. https://www.ncbi.nlm.nih.gov/pubmed/26488693
de Berker D, McGregor JM, Mohd Mustapa MF, Exton LS, Hughes BR. British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017. Br J Dermatol 2017;176(1):20-43.
Dianzani C, Conforti C, Giuffrida R, Corneli P, di Meo N, Farinazzo E, et al. Current therapies for actinic keratosis. Int J Dermatol 2020;59(6):677-84. https://www.ncbi.nlm.nih.gov/pubmed/32012240
Dirschka T, Gupta G, Micali G, Stockfleth E, Basset-Seguin N, Del Marmol V, et al. Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology. J Dermatolog Treat 2017;28(5):431-42. https://www.ncbi.nlm.nih.gov/pubmed/27796187
Giacalone S, Spigariolo CB, Bortoluzzi P, Nazzaro G. Oral nicotinamide: The role in skin cancer chemoprevention. Dermatol Ther 2021;34(3):e14892. https://www.ncbi.nlm.nih.gov/pubmed/33595161
Surjana D, Halliday GM, Martin AJ, Moloney FJ, Damian DL. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol 2012;132(5):1497-500. https://www.ncbi.nlm.nih.gov/pubmed/22297641
Weinstock MA, Thwin SS, Siegel JA, Marcolivio K, Means AD, Leader NF, et al. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial. JAMA Dermatol 2018;154(2):167-74. https://www.ncbi.nlm.nih.gov/pubmed/29299592
